Literature DB >> 4210424

Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors.

D R Schultz, K D Miller.   

Abstract

A purified elastase from Pseudomonas aeruginosa was highly destructive for fluid-phase and cell-bound C1 and C3 and fluid-phase C5, C8, and C9. Inactivation of C4, C2, C6, and C7 by the enzyme varied from 0 to 67%. Low concentrations of elastase generated, then inactivated, a chemotactic factor from human C5 but not from C3. Higher enzyme concentrations inactivated the C5 chemotactic activity at a faster rate. Elastase treatment of sensitized pseudomonads containing cell-bound C3 reduced the phagocytic indexes of polymorphonuclear leukocytes. The data support the proposed chemopathogenic role of the elastase in generation of the characteristic non-inflammatory Pseudomonas vasculitis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4210424      PMCID: PMC414968          DOI: 10.1128/iai.10.1.128-135.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  PSEUDOMONAS BURN WOUND SEPSIS. I PATHOGENESIS OF EXPERIMENTAL PSEUDOMONAS BURN WOUND SEPSIS.

Authors:  C TEPLITZ; D DAVIS; A D MASON; J A MONCRIEF
Journal:  J Surg Res       Date:  1964-05       Impact factor: 2.192

2.  ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.

Authors:  V H DONALDSON; F S ROSEN
Journal:  J Clin Invest       Date:  1964-11       Impact factor: 14.808

3.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

4.  Significance of selective vasculitis and the "bone-marrow" syndrome in Pseudomonas septicemia.

Authors:  W MARGARETTEN; H NAKAI; B H LANDING
Journal:  N Engl J Med       Date:  1961-10-19       Impact factor: 91.245

5.  Fatal pseudomonas infection in burned patients. A clinical, bacteriologic and anatomic study.

Authors:  E R RABIN; C D GRABER; E H VOGEL; R A FINKELSTEIN; W A TUMBUSCH
Journal:  N Engl J Med       Date:  1961-12-21       Impact factor: 91.245

Review 6.  Inborn and acquired abnormalities of the complement system of man.

Authors:  K F Austen
Journal:  Johns Hopkins Med J       Date:  1971-02

7.  Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.

Authors:  I Gigli; R A Nelson
Journal:  Exp Cell Res       Date:  1968-07       Impact factor: 3.905

8.  C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.

Authors:  P A Ward; J H Hill
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

9.  Complement-derived leukotactic factors in inflammatory synovial fluids of humans.

Authors:  P A Ward; N J Zvaifler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

10.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  50 in total

1.  Elastase deficiency phenotype of Pseudomonas aeruginosa canine otitis externa isolates.

Authors:  S R Petermann; C Doetkott; L Rust
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 2.  The Jeremiah Metzger Lecture. Microbial defenses against killing by phagocytes.

Authors:  G L Mandell; M O Frank
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

3.  Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.

Authors:  L W Heck; K Morihara; D R Abrahamson
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 4.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

5.  Effects of Pseudomonas aeruginosa elastase on alveolar epithelial permeability in guinea pigs.

Authors:  A O Azghani; J C Connelly; B T Peterson; L D Gray; M L Collins; A R Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

6.  Efficient production and processing of elastase and LasA by Pseudomonas aeruginosa require zinc and calcium ions.

Authors:  J C Olson; D E Ohman
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

7.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

8.  Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes.

Authors:  A N Neely; E J Law; I A Holder
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

9.  Effect of Pseudomonas aeruginosa cytotoxin on thymidine incorporation by murine splenocytes.

Authors:  T G Obrig; A L Baltch; T P Moran; S P Mudzinski; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  Pseudomonas aeruginosa lasB1 mutants produce an elastase, substituted at active-site His-223, that is defective in activity, processing, and secretion.

Authors:  K S McIver; J C Olson; D E Ohman
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.